Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Use of pillminders to dispense research medication.

Geller B, Fetner HH.

J Clin Psychopharmacol. 1989 Feb;9(1):72-3. No abstract available.

PMID:
2708562
2.

[Introducing a new psychotropic drug in psychiatry].

Vanelle JM, Goasguen D.

Soins Psychiatr. 1983 Nov;(37):31-8. French. No abstract available.

PMID:
6367068
3.

Psychopharmacology. The medication merry-go-round.

Brown K.

Science. 2003 Mar 14;299(5613):1646-9. No abstract available.

PMID:
12637713
4.

Direct data entry using a digitizing tablet in clinical trials.

Levine J, Summerfelt A.

Psychopharmacol Bull. 1989;25(2):246-9. No abstract available.

PMID:
2690168
5.

Guidelines for the evaluation of drugs in the elderly neuropsychiatric patients (demented and non-demented).

[No authors listed]

Pharmacopsychiatria. 1981 Sep;14(5):190-9. No abstract available.

PMID:
7291302
6.
7.

Once-a-day drug regimen for psychiatric patients.

Hasan MK, Mooney RP.

Am Fam Physician. 1981 Oct;24(4):123-5.

PMID:
6116425
8.

Integrating research projects into clinical service settings.

Madakasira S, Cain HI.

Hosp Community Psychiatry. 1988 Aug;39(8):888-90. No abstract available.

PMID:
2905339
9.

Brief review of current research in FXS: implications for treatment with psychotropic medication.

Valdovinos MG.

Res Dev Disabil. 2007 Nov-Dec;28(6):539-45. Epub 2006 Oct 10. Review.

PMID:
17034990
10.

Polypharmacy: when is it rational?

Preskorn SH, Lacey RL.

J Psychiatr Pract. 2007 Mar;13(2):97-105.

PMID:
17414685
11.

Psychotropic medication patterns among youth in foster care.

Zito JM, Safer DJ, Sai D, Gardner JF, Thomas D, Coombes P, Dubowski M, Mendez-Lewis M.

Pediatrics. 2008 Jan;121(1):e157-63. doi: 10.1542/peds.2007-0212.

PMID:
18166534
12.

Counselling and psychotropic drug prescribing.

Fahey T, Fletcher J.

Br J Gen Pract. 1996 Jan;46(402):49. No abstract available.

13.

An evaluation of fluphenazine with nortriptyline in anxiety and depression.

Anderson J, Lambert NG, Pigott PV.

Practitioner. 1972 Apr;208(246):511-7. No abstract available.

PMID:
4555519
14.

Comparison of a combination nortriptyline-amitriptyline and placebo on gastrointestinal diseases in a controlled clinical study.

Vrazda L, Langos J, Blazícek P, Vencel P, Pekár S.

Act Nerv Super (Praha). 1973 May;15(2):115-6. No abstract available.

PMID:
4584771
15.

[Off-label use of psychotropic medications in pediatric wards: a prospective study].

Winterfeld U, Le Heuzey MF, Acquaviva E, Mouren MC, Brion F, Bourdon O.

Arch Pediatr. 2009 Sep;16(9):1252-60. doi: 10.1016/j.arcped.2009.06.012. Epub 2009 Jul 28. French.

PMID:
19640689
16.

Therapeutic drug monitoring and drug-drug interactions: a pharmacoepidemiological perspective.

Balant-Gorgia AE, Gex-Fabry M, Balant LP.

Therapie. 1996 Jul-Aug;51(4):399-402.

PMID:
8953816
17.

Concerns about clinical drug trials.

Robinson DS, Rickels K.

J Clin Psychopharmacol. 2000 Dec;20(6):593-6. No abstract available.

PMID:
11106129
18.

Challenges in medication clinical trials.

Rudorfer MV.

Psychopharmacol Bull. 1993;29(1):35-44. Review.

PMID:
8378510
19.

Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project.

Rush AJ, Rago WV, Crismon ML, Toprac MG, Shon SP, Suppes T, Miller AL, Trivedi MH, Swann AC, Biggs MM, Shores-Wilson K, Kashner TM, Pigott T, Chiles JA, Gilbert DA, Altshuler KZ.

J Clin Psychiatry. 1999 May;60(5):284-91.

PMID:
10362434
20.

Psychotropic drug use and polypharmacy in a general hospital.

Salzman C.

Gen Hosp Psychiatry. 1981 Mar;3(1):1-9.

PMID:
6111514

Supplemental Content

Support Center